Investment Details
Investor Type
Private Equity
Asset Class Focus
Venture Capital
Stage Focus
Early Stage, Late Stage
Geographical Focus
United States
Industries Focus
- Healthcare
- Pharmaceuticals
- Biotechnology
Investor Details Founded: 2007
Arcus Ventures is a private equity firm specializing in investments in oncology-focused companies that are developing advanced biopharmaceuticals. The firm also invests in companies with new drug delivery platforms, device companies with pre-marketing approval, and service companies with positive revenue. Founded in 2007, Arcus Ventures is headquartered in New York, United States.
The firm's investment strategy targets both early and late-stage ventures, focusing on companies that are innovating in the field of oncology. By providing capital and strategic support, Arcus Ventures aims to accelerate the development and commercialization of groundbreaking cancer therapies.
Arcus Ventures has a track record of supporting companies that are at the forefront of oncology research and development, contributing to advancements in cancer treatment and patient care. Their portfolio reflects a commitment to fostering innovation and improving outcomes in the oncology sector.
Requirements
- Oncology focus
- Advanced biopharmaceuticals
- Positive revenue
Contact
[Official Website Hidden]
[HQ Location Hidden]
[Email Hidden]
[Contact Number Hidden]
Portfolio Companies
- MacroGenics
- Exosome Diagnostics
- Cleave Therapeutics
- XTuit Pharmaceuticals
- TRACON Pharmaceuticals
- Epic Sciences
- MI Bioresearch
Mentioned In
-
$14.95
-
$19.95
-
$24.95
-
$95.00
Claim this Investor
Are you an official representative of Arcus Ventures?
Claim this investor to update information, manage your profile, and get a verified seal.
Claim